Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma

Hugo J. A. Adams*, Thomas C. Kwee

*Corresponding author for this work

Research output: Contribution to journalLetter (Research letter)Academicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)129-131
Number of pages3
JournalBritish Journal of Haematology
Volume183
Issue number1
DOIs
Publication statusPublished - Oct-2018

Keywords

  • FDG-PET
  • Hodgkin lymphoma
  • response assessment
  • METAANALYSIS

Cite this